Home » Newsletters » BioWorld Science

BioWorld Science

June 29, 2004

View Archived Issues

IRA-01 shows fair antiarthritic effect, good safety and favorable lipid profile

SGN-15 and docetaxel combination promising in non-small cell lung cancer

Licofelone in symptomatic OA of the knee

Statins a potential therapeutic option in glaucoma

Vertex scientists prepare and test new inhibitors of JAK, JNK, CDK, etc.

Novel LTD4 antagonists and their use reported by Almirall Prodesfarma

Two series of MEK/c-Src kinase inhibitors claimed by AstraZeneca

New histamine H3 receptor ligands and their use claimed by Abbott

Oral PTH enters phase I trial under Unigene/GSK collaboration

IND accepted for phase II trials of Aplidin

New phase II trial of MDX-070 in hormone refractory prostate cancer

Millennium reacquires Integrilin European rights, licenses to GSK

Target enrollment met in phase III study of Campath for B-CLL

Closing date of Sanofi-Synthelabo's offer on Aventis postponed to July 30, 2004

Phase IIb trial of tgAAVCF for cystic fibrosis cleared to continue

XL-119 enters phase III trial in bile duct cancer

Change of indications for phase II trials of KOS-862

Singapore study for Dynavax HBV prophylactic vaccine

Sigma-Tau plans phase II European trial of TB4 for venous stasis ulcers

RI-624 enters phase I testing for pain

Positive interim results from phase I study of Davanat-1

Antiinflammatory and cardiovascular benefits found with atorvastatin in rheumatoid arthritis

Add-on therapy with safinamide improves motor function in Parkinson's disease

Therapeutic benefits of adjunctive istradefylline in advanced Parkinson's disease

French team prepares and tests a novel antithrombotic agent

Cyclacel claims new CDK inhibitors for cancer and viral infections

Repinotan study results reported at World Stroke Congress

Study parameters affect preclinical outcomes with neuroprotective agents

Study suggests simvastatin can prevent silent brain infarct

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...